• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

British T-cell cancer biotech Achilles Therapeutics guns for $176M IPO

cafead

Administrator
Staff member
  • cafead   Mar 26, 2021 at 11:02: AM
via Achilles Therapeutics is looking for a meaty $176 million initial public offering for its next-gen immuno-oncology work.

article source